Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Hovione receives the 2023 CDMO Leadership Award in all six categories and is Champion in Compatibility and Expertise 2023-03-08 22:00
The Next Generation of Smart home gym: Kickstarter Success - HooKee, to launch the Indiegogo Campaign 2023-03-07 21:20
MSCI ESG Updated I-Mab to "A" Rating 2023-03-07 21:02
AnPac Bio Announces Receipt of the First Payment from a Malaysia Customer On a Signed US$1.5 Million Cancer Detection Equipment Purchase Contract 2023-03-07 20:30
SiYi Intelligence Raises Nearly $15 Million in Series A Financing 2023-03-06 22:05
AnPac Bio-Medical Science Announces US$5 Million Private Placement 2023-03-06 21:30
HanAll Biopharma's Licensed Partner in China Announces Positive Topline Phase 3 Results for Batoclimab in Myasthenia Gravis 2023-03-06 20:00
Assure Tech Launches a New Platform - Comprehensive Health Solution 2023-03-06 18:47
Harbour BioMed Announces Positive Topline Results from Phase III Trial of Batoclimab for Treatment of Generalized Myasthenia Gravis 2023-03-06 14:27
US proteomics sector set for shake-up as new IonOpticks tech unveiled 2023-03-03 22:00
Neurophet to unveil new technology for analyzing ARIA side effect at ECR 2023 2023-03-02 22:00
Porton Advanced Collaborates with DanausGT to Accelerate the Development of Gene and Cell Therapy 2023-03-02 20:00
Sanyou Biopharmaceuticals opens Cambridge MA, US office, expanding its business outreach to a central hub of biotech network 2023-03-02 18:00
111 to Announce Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results- Conference Call to Follow 2023-03-02 15:35
ExoCoBio obtained 2 GMP Licenses for Exosome Biopharmaceuticals from Korea MFDS and for Hyaluronic Acid (HA) Dermal Fillers from Brazil ANVISA 2023-03-02 14:09
Maternity and Baby Brand Momcozy Launches 'Parachute Care Program' to Support Breastfeeding Journeys 2023-03-01 21:00
GenFleet receives EMA approval for phase Ib/II study of GFH925 (KRAS G12C inhibitor) in combination with ERBITUX® (cetuximab) treating patients with advanced NSCLC in first-line setting 2023-03-01 19:00
First in Class, Mabwell Announces the TGA Approval of 9MW3811 for IND 2023-02-28 23:00
Oricell Closes $45M Series B1 Financing to Expand Development of Key Products 2023-02-28 21:00
Gracell Biotechnologies to Participate in Oppenheimer 33rd Annual Healthcare Conference 2023-02-28 21:00
1 111 112 113 114 115 812